Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism Phosphatidylinositol 3-kinase family inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H33N9O2 |
InChIKeyIXWKZWYXLAMKND-UHFFFAOYSA-N |
CAS Registry2179265-86-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Preclinical | CN | 10 Dec 2019 |